16 years of Clinical experience, 6 years of basic research and 14 years of drug development.
Key areas of interest include
Duration: 5 months
Responsibility:
Duration: 31 months
Responsibility:
Duration: 5½ years
Responsibility:
Areas of responsibilities all malignancies (solid tumors) with focus on Heck and Neck, Gyn, Gastrointestinal, Mesothelioma and Malignant brain tumors, Lung cancer, Breast cancer and radiotherapy given to these malignancies as well as to pediatric malignancies.
Duration: 18 months
Responsibility:
Areas of responsibilities all malignancies (solid tumors) with focus on Heck and Neck
Duration: 32 months
Responsibility:
Ran two investigator initiated phased I trials, both completed. One presented as an abstract at ASCO 2+009 (abstract # 66) and one published in Anticancer Res (2012) open publication
Company Registration Number 27145876
Copyright 2023 © All rights reserved